KRAS G12D
Oncology·MeSH: Colorectal Neoplasms
5 drugs in development·4 companies·7 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| VS-7375 | ENANTA PHARMACEUTICALS INC (ENTA) |
Preclinical(2)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ARV-806 | ARVINAS, INC. (ARVN) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| sil204 | Silexion Therapeutics Corp (SLXN) |
Compare drugs
Frequently asked questions
How many drugs are in development for KRAS G12D?
BioSniper tracks 5 drugs in development for KRAS G12D across 4 companies.
How many clinical trials target KRAS G12D?
There are 7 clinical trials targeting KRAS G12D tracked by BioSniper.
Deep-dive into KRAS G12D
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis